Heart Disease Trial, Recruiting NCT06877195 Sponsor: Cardiochirurgia E.H. Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT06877195
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People undergoing either combined or isolated surgical interventions (confirm with trial site)
  • People whose veins are of a suitable size for the procedure
  • People whose graft blood flow measurements meet the required levels

Who may not be able to join:

  • People whose veins and grafts are not compatible in size, making implantation not possible
  • People whose graft blood flow measurements are not at an adequate level for the procedure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Luca Paolo Weltert, MD, Unicamillus

Phone: +393478880617

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cardiochirurgia E.H.
Registry
ClinicalTrials.gov
Start date
1 March 2025
Est. completion
1 March 2028

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Ri-revascularization of grafted territory

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov